AMA Medical Manufacturing Limited, in partnership with Barbados Pharmaceutical Inc., is developing an intravenous (IV) fluid manufacturing facility in Barbados. The facility will produce approximately 12 million IV fluid units annually using advanced aseptic form-fill-seal (AFFS) technology to support sterility, production efficiency and international quality standards. The project aims to strengthen Barbados' pharmaceutical manufacturing capacity and reduce reliance on imported IV fluids and other essential medical supplies. Local production is expected to improve access to critical healthcare products while supporting greater supply chain resilience. The facility will also serve regional markets across CARICOM and Latin America, contributing to the development of Barbados as a pharmaceutical manufacturing hub. In addition, the project will support the development of specialised local expertise in sterile manufacturing, Good Manufacturing Practice (GMP) standards and quality assurance. Renewable energy options, including rooftop solar, are also being considered as part of the facility's development.
Project overview
Investment opportunity
The project offers an opportunity to invest in the growing pharmaceutical manufacturing industry while addressing regional demand for essential medical supplies. With a USD 32 million project, the initiative is positioned to strengthen healthcare supply chains and expand Barbados' role in pharmaceutical exports across CARICOM, Latin America and the wider Global South. Investors can participate in developing local manufacturing capacity in a sector critical to healthcare supply security. Local production is expected to reduce reliance on imported IV fluids, lower costs by up to 50% for consumers and 20% for government procurement, and improve access to essential medical products. The project is also expected to create 147-214 direct jobs, with a further 100 residual jobs projected, while developing specialised local expertise. Sustainable design features, including solar energy and seawater cooling, further support efficient manufacturing and Barbados' green economy ambitions.
Investment types sought
Project status
Development stage
Bankable / investment ready
Current status / progress to date
The project is bankable and investment-ready and is currently seeking strategic partners and financing to support implementation. Project planning, feasibility assessments and investment preparation activities have been completed, and the project is advancing towards financial close and delivery of the manufacturing facility.
Additional project information
- Lead agency
- Invest Barbados
Expected impact
Jobs created / supported
The project is expected to create 147-214 direct jobs, with a further 100 residual jobs projected. It will also support local skills development and expand employment opportunities within Barbados' pharmaceutical manufacturing sector.
Economic & development benefits
- GDP contribution of approximately 0.13%-0.14% to annual GDP, strengthening Barbados' productive capacity and economic output
- Creates an estimated 147-214 direct factory jobs, with a further 100 residual jobs projected, supporting household incomes and wider economic activity
- Builds specialised local expertise through training in sterile manufacturing, Good Manufacturing Practice (GMP) and quality assurance
- Reduces dependence on imported IV fluids and other essential medicines, retaining more economic value within Barbados
- Expands export opportunities across CARICOM, Latin America and the wider Global South, supporting Barbados' development as a pharmaceutical manufacturing hub
Climate & resilience benefits
- Incorporates solar energy to reduce reliance on conventional electricity sources and support lower-carbon pharmaceutical manufacturing
- Uses seawater cooling to reduce dependence on conventional cooling systems and improve resource efficiency
- Supports climate change mitigation through the integration of renewable energy and alternative cooling systems
- Contributes to sustainable industrial development and supports Barbados' transition towards a greener economy
- Aligns with Barbados' 2030 Green Economy Goals
Contact
Contact team
For more information about this project, please contact the Commonwealth Investment Platform team.